2023년 03월 23일 디어젠 주식회사 대표이사 강 길 수
Read More
Technical & News Articles about Deargen
2023년 03월 23일 디어젠 주식회사 대표이사 강 길 수
Read More당사는 이사회 결의로 상법 제363조 및 당사 정관에 의거하여 아래와 같이 정기주주총회를 개최하고자 통지하오니 참석하여 주시기 바랍니다.
Read MoreDeargen applied patent for a novel target compound candidate.
Read MoreDeargen collaboration with Samsung Seoul Hospital, to discover new Alzheimer’s treatments using AI technology.
Read MoreAt ACM CHIL 2021, Deargen presented study results on a model of simultaneously optimizing multiple properties of molecules.
Read MoreDeargen: Laveraging AI to Accelerate New Drug Development.
Read MoreDeargen and Uptera selected two target proteins, including anti-cancer drugs, and signed a joint research contract.
Read MoreAI-based Drug Discovery, What would be the limitation?
Read MoreHANDOK and Deargen will conduct joint researches on “oncology” and other diseases using DearDTI.
Read MoreDeargen collaboration with IN Therapeutics collaboration to develop a treatment for hearing loss.
Read More